A patient who had previously undergone ileal resection and liver transplantation for a gastroenteropancreatic (GEP) tumor was evaluated with somatostatin receptor scintigraphy (SRS) using 111In-DTPA-D-Phe1-pentetreotide. Eighteen months after surgery, during follow-up procedures, conventional imaging techniques (ultrasound, computed tomography, magnetic resonance imaging) only showed a relapse in the gastropancre-atic lymph nodes, while SRS demonstrated skeletal spread. This case report emphasizes the clinical impact of SRS on the management of patients affected by neuroendocrine gastroenteropancreatic tumors.
CapellaC., HeitzP.U., HòflerH., SolciaE., KloppelG.: Revised classification of neuroendocrine tumours of the lung, pancreas and gut.Virchows Archiv.,425: 547–560, 1995.
2.
JamarF., FiasseR., LenersN., PauwelsS.: Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management.J. Nucl. Med.,36: 542–549, 1995.
KrenningE.P., KwekkeboomD.J., BakkerW.H., BreemanW.A.P., KooijP.P.M., OeiH.Y., van HagenM., PostemaP.T.E., de JongM., ReubiJ.C., VisserT.J., ReijsA.E.M., HoflandL.J., KoperJ.W., LambertsS.W.J.: Somatostatin receptor scintigraphy with [mIn-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.Eur. J. Nucl. Med.,20: 716–731, 1993.
5.
KwekkeboomD.J., KrenningE.P., BakkerW.H., OeiH.Y., KooijP.P.M., LambertsS.W.J.: Somatostatin analogue scintigraphy in carcinoid tumours.Eur. J. Nucl. Med.,20: 283–292, 1993.
6.
LambertsS.W.J., KrenningE.P., ReubiJ.C.: The role of somatostatin and its analogs in the diagnosis and treatment of tumors.Endocr. Rev.,12: 450–482, 1991.
7.
ModlinI.M., CorneliusE., LawtonG.P.: Use of an isotopic somatostatin receptor probe to image gut endocrine tumors.Arch. Surg.,130: 367–374, 1995.
8.
SchillaciO., ScopinaroF., AngelettiS., TavolaroR., DanieliR., AnnibaleB., GualdiG., Delle FaveG.: SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors.J. Nucl. Med.,37: 1452–1456, 1996.
9.
ZimmerT., ZieglerK., BäderM., FettU., HammB., Rieck-enE.O., WiedenmannB.: Localization of neuroendocrine tumours of the upper gastrointestinal tract.Gut,35: 471–475, 1994.
